Noticias

HTC update on SPM research for patients and visiting practitioners

1:14 am 8 October 2026 0 Comments

This update from Health Therapies Clinics is written for two audiences: patients, and practitioners who hire rooms in our clinics.

For practitioners

On 7 October 2026 Metagenics circulated information about a practitioner and patient only SPM product, now offered in a larger pack size to practitioners. Under advertising rules for this category, HTC does not name or promote it publicly. The communication cited Callan, Hanes and Bradley (J Transl Med, 2020), an open-label single-arm study in adults with chronic pain, and Moller and colleagues (J Transl Med, 2023, the GAUDI study), a randomised, double-blind, placebo-controlled trial in symptomatic knee osteoarthritis. Room hirers wishing to review the papers or the product should do so directly through their own Metagenics accounts.

For patients

SPMs, or specialised pro-resolving mediators, are compounds formed from omega-3 fatty acids and studied for their part in resolving inflammation. The research is ongoing. Our Healthy Market sells Metagenics products, and any suggestion is made by a practitioner after an individual assessment that includes your medicines.

Patients with questions about SPMs can raise them at their next consultation. Bookings: 0410 699 065.

Comments are disabled

Buscar
Archives
Recent entries
Categories